Job Scope:
The Sr. Strategic Account Manager is expected to lead the industrial enzymes and biofuel ethanol market in the Americas region and focuses on a go-to-market approach while achieving a sustainable sales pipeline. The position can be based remotely throughout the United States with the territory being North America and Latin America.
Key Responsibilities:
- Responsible to develop grain processing business particularly in biofuel ethanol in America region as per aligned with organizational mission and targets.
- Develop go-to-market strategy with key action plans based on in-depth understanding of the industry trend, competitor, market needs, resources and support requirement, etc.
Qualifications:
- Excellent written and verbal communication, interpersonal and teamwork skills.
- Comfortable with multi-cultural and remote working environment, with strong proactiveness to work across functions internally and externally.
- Strong analytical and problem-solving skills to effectively drive opportunities and address challenges.
- Strong background in the biofuel ethanol or grain processing industry.
- Senior commercial experience with specialty chemicals or enzymes, including direct and indirect sales via sales channels.
- Technical experience and people management skills are added advantages.
- Proficient with Microsoft Office or related software, and CRM
Education and Experience:
- At least a B.S. in Chemistry/Biotechnology/Chemical Engineering or any relevant fields
- Minimum 3 years working experience in biofuel ethanol or grain processing industry.
Working Conditions:
- Remote working with travel required up to 50%
#LI-EB1
#GS
GenScript USA Inc/ProBio Inc. is a proud equal opportunity/affirmative action employer committed to attracting, retaining, and maximizing the performance of a diverse and inclusive workforce. It is the Company's policy to ensure equal employment opportunity without discrimination or harassment based on race, color, religion, sex (including pregnancy, childbirth, or related medical conditions), sexual orientation, gender identity or expression, age, disability, national origin, marital or domestic/civil partnership status, genetic information, citizenship status, uniformed service member or veteran status, or any other characteristic protected by law.
GenScript USA Inc./ProBio Inc. maintains a drug-free workplace.
Please note: Genscript USA Inc./ProBio Inc. will only contact candidates through verified application sources. GenScript/Probio does not request personal information from candidates through individual email or any other platform.
GenScript Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about GenScript and has not been reviewed or approved by GenScript.
-
Healthcare Strength — Feedback suggests medical coverage is solid, with mentions of comprehensive health plans and employer HSA support in some options. Company communications also emphasize robust health benefits alongside wellbeing and training initiatives.
-
Leave & Time Off Breadth — Feedback suggests a range of paid time off types, including vacation, sick time, company holidays, and additional leave categories. Some roles reference flexible vacation arrangements that broaden usable time off.
-
Retirement Support — Feedback suggests retirement offerings include a 401(k) with company match in certain postings. This provides a longer-term savings component within total rewards.
GenScript Insights
Similar Jobs
.png)
What We Do
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions worldwide have used GenScript’s premier, convenient, and reliable products and services. GenScript currently has over 5,000 employees globally, 33% holding master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis, and bioinformatics, including more than 100 patents and over 270 patent applications. As of June 2022, GenScript's products and services have been cited by 74,700 scientific papers worldwide. GenScript is committed to striving toward its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.
